These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chemoprevention strategies for patients with lung cancer in the context of screening. Saba NF; Khuri FR Clin Lung Cancer; 2005 Sep; 7(2):92-9. PubMed ID: 16179095 [TBL] [Abstract][Full Text] [Related]
3. Prevention of lung cancer. The new millennium. Kim ES; Hong WK; Khuri FR Chest Surg Clin N Am; 2000 Nov; 10(4):663-90, v. PubMed ID: 11091919 [TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of lung cancer: soon daily practice? van Zandwijk N; Pastorino U Expert Rev Anticancer Ther; 2003 Feb; 3(1):91-8. PubMed ID: 12597353 [TBL] [Abstract][Full Text] [Related]
5. [New therapeutic targets and strategies in lung cancer]. Sánchez De Cos Escuín J Arch Bronconeumol; 2002 Aug; 38(8):386-91. PubMed ID: 12199921 [No Abstract] [Full Text] [Related]
6. Farnesyltransferase inhibitors. Adjei AA Cancer Chemother Biol Response Modif; 2002; 20():151-67. PubMed ID: 12703204 [No Abstract] [Full Text] [Related]
7. Perspectives on farnesyl transferase inhibitors in cancer therapy. Mazieres J; Pradines A; Favre G Cancer Lett; 2004 Apr; 206(2):159-67. PubMed ID: 15013521 [TBL] [Abstract][Full Text] [Related]
8. Expression of target molecules in lung cancer: challenge for a new treatment paradigm. Hirsch FR; Franklin WA; Bunn PA Semin Oncol; 2002 Jun; 29(3 Suppl 9):2-8. PubMed ID: 12094332 [TBL] [Abstract][Full Text] [Related]
9. [Chemoprevention of lung cancer]. Ayoub J; Ying Y; Bradley WE Union Med Can; 1993; 122(6):442-5. PubMed ID: 8303787 [TBL] [Abstract][Full Text] [Related]
11. Current status of retinoid chemoprevention of lung cancer. Benner SE; Lippman SM; Hong WK Oncology (Williston Park); 1995 Mar; 9(3):205-10; discussion 210, 213-4, 216. PubMed ID: 7669514 [TBL] [Abstract][Full Text] [Related]
12. [Update on antitumor pharmacology: reality and perspectives in 1998]. Lavelle F; Jehanno A Bull Cancer; 1998 Jan; 85(1):83-8. PubMed ID: 9752357 [No Abstract] [Full Text] [Related]
13. [Retinoids and carotenoids in cancer chemoprevention trials]. Hattchouel JM; Laplanche A Bull Cancer; 1992; 79(10):957-62. PubMed ID: 1292762 [TBL] [Abstract][Full Text] [Related]
14. Farnesyltransferase inhibitors as anticancer agents: current status. Zhu K; Hamilton AD; Sebti SM Curr Opin Investig Drugs; 2003 Dec; 4(12):1428-35. PubMed ID: 14763128 [TBL] [Abstract][Full Text] [Related]
15. Molecularly targeted approaches to the chemoprevention of lung cancer. Khuri FR; Cohen V Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4249s-4253s. PubMed ID: 15217968 [TBL] [Abstract][Full Text] [Related]
16. Vitamin A analogues in cancer chemoprevention. Hennekens CH Important Adv Oncol; 1986; ():23-35. PubMed ID: 3330535 [No Abstract] [Full Text] [Related]
17. Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations. Brunner TB; Hahn SM; Gupta AK; Muschel RJ; McKenna WG; Bernhard EJ Cancer Res; 2003 Sep; 63(18):5656-68. PubMed ID: 14522880 [TBL] [Abstract][Full Text] [Related]
18. Cigarettes: a smoking gun in cancer chemoprevention. Mayne ST; Lippman SM J Natl Cancer Inst; 2005 Sep; 97(18):1319-21. PubMed ID: 16174848 [No Abstract] [Full Text] [Related]
19. Inhibitors of farnesyltransferase: a rational approach to cancer chemotherapy? Bell IM J Med Chem; 2004 Apr; 47(8):1869-78. PubMed ID: 15055985 [No Abstract] [Full Text] [Related]
20. Chemoprevention of lung cancer. Huber MH; Lee JS; Hong WK Semin Oncol; 1993 Apr; 20(2):128-41. PubMed ID: 8480185 [No Abstract] [Full Text] [Related] [Next] [New Search]